DJIA 17,042.90 -28.32 -0.17%
NASDAQ 4,493.39 -12.46 -0.28%
S&P 500 1,972.29 -5.51 -0.28%
market minute promo

Amicus Therapeutics, Inc. (NASDAQ: FOLD)

5.95 -0.14 (-2.30%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

FOLD $5.95 -2.30%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.11
Previous Close $6.09
Daily Range $5.86 - $6.17
52-Week Range $1.77 - $7.63
Market Cap $468.3M
P/E Ratio -6.34
Dividend (Yield) $0.00 (0.0%)
Volume 1,013,314
Average Daily Volume 3,681,444
Current FY EPS -$0.89

Sector

Healthcare

Industry

Drugs

Amicus Therapeutics, Inc. (FOLD) Description

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. Website: http://www.amicusrx.com/

News & Commentary

Why Amicus Therapeutics, Inc. Stock Is Soaring Today

Amicus Therapeutics' shares are soaring today. Here's why.

3 Cheap Biotech Stocks Analysts Love: Ohr Pharmaceutical Inc, Merrimack & Amicus

Why Amicus Therapeutics (FOLD) Stock Might be a Great Pick - Tale of the Tape

Why Amicus Therapeutics (FOLD) Stock Might be a Great Pick - Tale of the Tape

Top 5 Performing Biotech Stocks Of 2014

Morning Market Movers

Amicus Therapeutics (FOLD) Stock Rises on High Volume

Perilous Reversal Watch: Amicus Therapeutics (FOLD)

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Bl

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog

Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog

The Biotech Stock With The Best One-Week Performance

Five Billionaire-Owned Biotech Stocks You Could Acquire for 100%

See More FOLD News...

FOLD's Top Competitors

FOLD $5.95 (-2.30%)
Current stock: FOLD
AMGN $140.46 (0.28%)
Current stock: AMGN
GILD $106.45 (-0.99%)
Current stock: GILD
BIIB $330.81 (0.20%)
Current stock: BIIB